- Aktuelle Seite:
-
Home
-
Substitutionsmittel
-
Verschiedenes
- Association between serum concentrations of natriuretic peptides and perceived withdrawal symptoms in opiate maintenance
Opioid use disorder and treatment: challenges and opportunities.
Hoffman KA, Ponce Terashima J, McCarty D.
BMC Health Serv Res. 2019 Nov 25;19(1):884. doi: 10.1186/s12913-019-4751-4.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6876068/
Adjunctive memantine for opioid use disorder treatment: A systematic review.
Elias AM, Pepin MJ, Brown JN.
J Subst Abuse Treat. 2019 Dec;107:38-43. doi: 10.1016/j.jsat.2019.10.003.
https://www.ncbi.nlm.nih.gov/pubmed/31757263
Fentanyl assisted treatment: a possible role in the opioid overdose epidemic?
Bardwell G, Wood E, Brar R.
Subst Abuse Treat Prev Policy. 2019 Nov 11;14(1):50. doi: 10.1186/s13011-019-0241-2.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849248/
Sustained-release Oral Hydromorphone for the Treatment of Opioid Use Disorder.
Braithwaite V, Fairgrieve C, Nolan S.
J Addict Med. 2019 Oct 25. doi: 10.1097/ADM.0000000000000585.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31658114
Neue Substitutionsprodukte, neue Chancen? Der Wurm muss dem Fisch schmecken, nicht dem Angler (Präsentation)
Dr. Manfred Nowak, Landau
NaSuKo – 5.Nationale Substitutionskonferenz, 27.09.2019, Berlin
https://www.akzept.eu/wp-content/uploads/2019/10/NeueSubstitutionsmittelNowak.pdf
Current status of opioid addiction treatment and related preclinical research.
Kreek MJ, Reed B, Butelman ER.
Sci Adv. 2019 Oct 2;5(10):eaax9140. doi: 10.1126/sciadv.aax9140. eCollection 2019 Oct. Review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774730/
Norwegen. 'The entire pharmaceutical compendium' in the treatment of substance use disorders
Jørg Mørland, Helge Waal
Tidsskr Nor Legeforen 2019, doi: 10.4045/tidsskr.18.0678
Medication-Assisted Treatment for Opioid-Use Disorder.
Tyler S. Oesterle, Nuria J. Thusius, Teresa A. Rummans, Mark S. Gold.
Mayo Clinic Proceedings, 2019; DOI: 10.1016/j.mayocp.2019.03.029
https://www.mayoclinicproceedings.org/article/S0025-6196(19)30393-3/fulltext
Anästhesievorbereitung: Welche Medikamente vor einer Narkose abgesetzt werden sollten
Schreiner, Mathias J.; Kehl, Franz
Dtsch Arztebl 2019; 116(31-32): A-1428 / B-1183 / C-1167
Pain management in opioid maintenance treatment.
Koller G, Schwarzer A, Halfter K, Soyka M.
Expert Opin Pharmacother. 2019 Aug 16:1-13. doi: 10.1080/14656566.2019.1652270.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31418602
Opioid Addiction, Genetic Susceptibility, and Medical Treatments: A Review.
Wang SC, Chen YC, Lee CH, Cheng CM.
Int J Mol Sci. 2019 Sep 2;20(17). pii: E4294. doi: 10.3390/ijms20174294.
https://www.mdpi.com/1422-0067/20/17/4294/htm
Effects of Parental Opioid Use: Outcomes of Children of Parents in Medication-Assisted Treatment Compared to Healthy Controls.
Betcher HK, Vande Voort JL, Croarkin PE, Gandhi KD, Shekunov J, Larrabee BR, Limbeck MG, Rummans TA, Romanowicz M.
Prim Care Companion CNS Disord. 2019 Aug 15;21(4). pii: 19m02474. doi: 10.4088/PCC.19m02474.
http://www.psychiatrist.com/pcc/article/pages/2019/v21n04/19m02474.aspx
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, Bagley SM, Liebschutz JM, Walley AY.
Ann Intern Med. 2018 Aug 7;169(3):137-145. doi: 10.7326/M17-3107.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387681/
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.
Molero Y, Zetterqvist J, Binswanger IA, Hellner C, Larsson H, Fazel S.
Am J Psychiatry. 2018 Oct 1;175(10):970-978. doi: 10.1176/appi.ajp.2018.17101112.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169735/
Opioid Use Disorders: Perioperative Management of a Special Population.
Ward EN, Quaye AN, Wilens TE.
Anesth Analg. 2018 Aug;127(2):539-547. doi: 10.1213/ANE.0000000000003477.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523021/
Palliativversorgung von Patienten in Opioidsubstitutionsbehandlung (mit CME)
Hoffmann-Menzel, J.Goldmann, M.Kern, K.Weckbecker, L. Wüllenweber, L. Radbruch
Schmerz 2019 · 33:263–280, doi.org/10.1007/s00482-019-0376-0
Abstract (freier Zugang für 14 Tage möglich)
Korrespondenzadresse: Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!
Sex differences in high opioid dose escalation among Malaysian patients with long term opioid therapy.
Zin CS, Alias NE, Taufek NH, Ahmad MM.
J Pain Res. 2019 Apr 24;12:1251-1257. doi: 10.2147/JPR.S199243.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499483/
Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood.
Leventelis C, Goutzourelas N, Kortsinidou A, Spanidis Y, Toulia G, Kampitsi A, Tsitsimpikou C, Stagos D, Veskoukis AS, Kouretas D.
Oxid Med Cell Longev. 2019 Apr 9;2019:9417048. doi: 10.1155/2019/9417048.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481042/
Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
Gastberger S, Baumgartner MR, Soyka M, Quednow BB, Hulka LM, Herdener M, Seifritz E, Mutschler J.
Eur Addict Res. 2019 May 8:1-6. doi: 10.1159/000500542.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/31067528
Detection of heroin intake in patients in substitution treatment using oral fluid as specimen for drug testing.
Böttcher M, Lierheimer S, Peschel A, Beck O.
Drug Alcohol Depend. 2019 Mar 23;198:136-139. doi: 10.1016/j.drugalcdep.2019.02.011.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/30927716
Impact of Substance Use Disorder Pharmacotherapy on Executive Function: A Narrative Review.
Butler K, Le Foll B.
Front Psychiatry. 2019 Mar 1;10:98. doi: 10.3389/fpsyt.2019.00098.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405638/
Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine.
Noble F, Marie N.
Front Psychiatry. 2019 Jan 18;9:742. doi: 10.3389/fpsyt.2018.00742. eCollection 2018. Review.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345716/
Comparing opium tincture and methadone for medication-assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double-blind randomized controlled trial.
Nikoo M, Moazen-Zadeh E, Nikoo N, Javidanbardan S, Kazemi A, Choi F, Vogel M, Gholami A, Tavakoli S, Givaki R, Jazani M, Mohammadian F, Markazi Moghaddam N, Goudarzi N, Schutz C, Jang K, Akhondzadeh S, Krausz M.
Int J Methods Psychiatr Res. 2019 Feb 4:e1768. doi: 10.1002/mpr.1768.
Abstract
https://www.ncbi.nlm.nih.gov/pubmed/30714249
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?.
Marsden, J., Tai, B., Ali, R., Hu, L., Rush, A. J., and Volkow, N. (2019)
Addiction, doi.org/10.1111/add.14546.
https://onlinelibrary.wiley.com/doi/10.1111/add.14546
Temperamental Characteristics and Problem-Solving Skills among Patients on Opioid Agonists.
Eslami-Saaraab S, Eslami-Shahrbabaki H, Eslami-Shahrbabaki M, Motaghyan S.
Addict Health. 2018 Jan;10(1):24-31. doi: 10.22122/ahj.v10i1.579.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312562/
Change in alcohol and other drug use during five years of continuous opioid substitution treatment
Brian Eastwood, John Strang and John Marsden
Drug and Alcohol Dependence, Volume 194, 1 January 2019, Pages 438-446, doi.org/10.1016/j.drugalcdep.2018.11.008
https://www.sciencedirect.com/science/article/pii/S0376871618304897#bib0100
Substitution von A bis Z
Mit der vorliegenden Broschüre möchten wir Ihnen ein Nachschlagewerk an die Hand geben, welches die Grundlagen der Suchttherapie von A bis Z vermittelt und Ihnen daher im Alltag ein hilfreicher Begleiter sein kann. Vor allem Personen, die noch wenig Erfahrung mit der Substitutionsbehandlung haben, sollen unterstützt werden, sich schnell in das Therapiegebiet einzufinden und die Arbeitsabläufe kennen zu lernen. (Hexal, 2018)
Sanofi Kompendium Substitutionsmedizin – Neuauflage 2018
Das neue Kompendium Substitutionsmedizin bietet allen Ärzten, die in der Praxis mit Suchtmedizin zu tun haben, einen umfassenden Einblick in die verschiedenen Aspekte der Opiatsubstitutionstherapie. Das Kompendium wurde erweitert um die aktuelle Rechtslage und richtet sich auch an ApothekerInnen als zusätzliche Zielgruppe
Das Kompendium kann aufgerufen und runtergeladen werden auf der Substitutionsseite von Sanofi. Die Druckausgabe kann über den Außendienst von Sanofi bestellt werden.
https://www.substitutionsportal.de/
One size does not fit all – evolution of opioid agonist treatments in a naturalistic setting over 23 years.
Nordt, C., Vogel, M., Dey, M., Moldovanyi, A., Beck, T., Berthel, T., Walter, M., Seifritz, E., Dürsteler, K. M., and Herdener, M. (2018)
Addiction, doi.org/10.1111/add.14442.
Abstract
https://onlinelibrary.wiley.com/doi/10.1111/add.14442
SAMHSA. Medications for opioid use disorder: for healthcare and addiction professionals, policymakers, patients, and families: Treatment Improvement Protocol: TIP 63.
Substance Abuse and Mental Health Services Administration
[US] Substance Abuse and Mental Health Services Administration, 2018
https://store.samhsa.gov/shin/content/SMA18-5063FULLDOC/SMA18-5063FULLDOC.pdf
Seite 1 von 4